The epidemiology of longevity and exceptional survival

Epidemiologic Reviews

Volumn 35, Issue 1, 2013, Pages 181-197

  Newman, Anne B ^a,b   Murabito, Joanne M ^c,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

aging; exome; genetics; genome; longevity

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; EXONUCLEASE; LAMIN A; LAMIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTOME;

AGING; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHROMOSOME 9P; COHORT ANALYSIS; DEMOGRAPHY; EPIGENETICS; EXOME; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HUMAN; LIFE EXPECTANCY; LIFESPAN; LIFESTYLE; LONGEVITY; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; CARDIOVASCULAR DISEASES; FEMALE; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEALTH BEHAVIOR; MALE; PROTECTION; REPRODUCTIVE HISTORY; RISK FACTOR; SEX DIFFERENCE; SMOKING; VERY ELDERLY;

AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; EPIGENESIS, GENETIC; EXOME; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEALTH BEHAVIOR; HUMANS; LONGEVITY; MALE; PROTECTIVE FACTORS; REPRODUCTIVE HISTORY; RISK FACTORS; SEX FACTORS; SMOKING; TRANSCRIPTOME;

EID: 84874470734     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxs013     Document Type: Article

References (128)

1. Suzman R, Riley MW Introducing the "oldest old." Milbank Mem Fund Q Health Soc. 1985;63(2):177-186.
2. He W, Muenchrath MN. 90+ in the United States: 2006-2008. (American Community Survey Reports, no. ACS-17). Washington, DC: US GPO; 2011.
3. Arias E. United States life tables, 2000. Natl Vital Stat Rep. 2002;51(3):1-38.
4. Robine JM, Allard M. The oldest human. Science. 1998; 279(5358):1834-1835.
5. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science. 2002;296(5570):1029-1031.
6. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058. (doi:10.1371/journal. pmed.1000058).
7. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2012: Key Indicators of Well-Being. Washington, DC: US GPO; 2012.
8. Hjelmborg JVB, Iachine I, Skytthe A, et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119(3):312-321.
9. Wilmoth JR. The future of human longevity: a demographer's perspective. Science. 1998;280(5362):395-397.
10. Fried L. What are the roles of public health in an aging society? In: Prohaska TR, Anderson LA, Binstock RH, eds. Public Health for an Aging Society. 1st ed. Baltimore, MD: The Johns Hopkins University Press; 2012:26.
11. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138-1145.
12. Andersen SL, Sebastiani P, Dworkis DA, et al. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci. 2012;67(4):395-405.
13. Cho J, Martin P, Poon LW. The older they are, the less successful they become? Findings from the Georgia Centenarian Study. J Aging Res. 2012;2012:695854. (doi:10.1155/2012/695854).
14. Willcox BJ, He Q, Chen R, et al. Midlife risk factors and healthy survival in men. JAMA. 2006;296(19):2343-2350.
15. Perls TT, Wilmoth J, Levenson R, et al. Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A. 2002;99(12):8442-8447.
16. Kerber RA, O'Brien E, Smith KR, et al. Familial excess longevity in Utah genealogies. J Gerontol A Biol Sci Med Sci. 2001;56(3):B130-B139.
17. Gudmundsson H, Gudbjartsson DF, Frigge M, et al. Inheritance of human longevity in Iceland. Eur J Hum Genet. 2000;8(10):743-749.
18. Terry DF, Wilcox MA, McCormick MA, et al. Cardiovascular disease delay in centenarian offspring. J Gerontol A Biol Sci Med Sci. 2004;59(4):385-389.
19. Terry DF, Wilcox MA, McCormick MA, et al. Lower all-cause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc. 2004;52(12): 2074-2076.
20. Willcox DC, Willcox BJ, Poon LW. Centenarian studies: important contributors to our understanding of the aging process and longevity. Curr Gerontol Geriatr Res. 2010;2010:484529. (doi:10.1155/2010/484529).
21. Westendorp RGJ, Van Heemst D, Rozing MP, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: the Leiden Longevity Study. J Am Geriatr Soc. 2009;57(9): 1634-1637.
22. Newman AB, Glynn NW, Taylor CA, et al. Health and function of participants in the Long Life Family Study: a comparison with other cohorts. Aging (Albany NY). 2011;3(1):63-76.
23. Rajpathak SN, Liu Y, Ben-David O, et al. Lifestyle factors of people with exceptional longevity. J Am Geriatr Soc. 2011;59(8):1509-1512.
24. Perls T, Shea-Drinkwater M, Bowen-Flynn J, et al. Exceptional familial clustering for extreme longevity in humans. J Am Geriatr Soc. 2000;48(11):1483-1485.
25. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282(21):2012-2018.
26. Baer HJ, Glynn RJ, Hu FB, et al. Risk factors for mortality in the Nurses' Health Study: a competing risks analysis. Am J Epidemiol. 2011;173(3):319-329.
27. Terry DF, Pencina MJ, Vasan RS, et al. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc. 2005;53(11):1944-1950.
28. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279(8):585-592.
29. Newman AB, Sachs MC, Arnold AM, et al. Total and cause-specific mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2009;64(12): 1251-1261.
30. Walter S, Mackenbach J, Vokó Z, et al. Genetic, physiological, and lifestyle predictors of mortality in the general population. Am J Public Health. 2012;102(4): e3-e10.
31. Noale M, Minicuci N, Bardage C, et al. Predictors of mortality: an international comparison of socio-demographic and health characteristics from six longitudinal studies on aging: the CLESA project. Exp Gerontol. 2005;40(1-2): 89-99.
32. Burke GL, Arnold AM, Bild DE, et al. Factors associated with healthy aging: the Cardiovascular Health Study. J Am Geriatr Soc. 2001;49(3):254-262.
33. Newman AB, Arnold AM, Naydeck BL, et al. "Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med. 2003;163(19):2315-2322.
34. Yates LB, Djoussé L, Kurth T, et al. Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Intern Med. 2008;168(3): 284-290.
35. Sanders JL, Boudreau RM, Newman AB. Understanding the aging process using epidemiologic approaches. In: Newman AB, Cauley JA, eds. The Epidemiology of Aging. 2012 ed. New York, NY: Springer Publishing Company; 2013:187.
36. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science. 2010;328(5976): 321-326.
37. Kenyon CJ. The genetics of ageing. Nature. 2010; 464(7288):504-512.
38. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011;10(3):319-329.
39. Semba RD, Bandinelli S, Sun K, et al. Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc. 2009; 57(10):1874-1880.
40. Cappola AR, Xue Q-L, Ferrucci L, et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab. 2003;88(5):2019-2025.
41. Austad SN. Why women live longer than men: sex differences in longevity. Gend Med. 2006;3(2):79-92.
42. Newman AB, Brach JS. Gender gap in longevity and disability in older persons. Epidemiol Rev. 2001;23(2):343-350.
43. Kinsella K, He W. An Aging World: 2008. (International Population Reports, no. P95/09-1). Washington, DC: US GPO; 2009:196.
44. Poulain M, Pes G, Salaris L. A population where men live as long as women: Villagrande Strisaili, Sardinia. J Aging Res. 2011;2011:153756.
45. Finch CE, Kirkwood TB. Chance, Development, and Aging. New York, NY: Oxford University Press; 2000.
46. Lakshman R, Forouhi NG, Sharp SJ, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab. 2009;94(12): 4953-4960.
47. Jacobsen BK, Heuch I, Kvåle G. Association of low age at menarche with increased all-cause mortality: a 37-year follow-up of 61, 319 Norwegian women. Am J Epidemiol. 2007;166(12):1431-1437.
48. Jacobsen BK, Oda K, Knutsen SF, et al. Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88. Int J Epidemiol. 2009;38(1):245-252.
49. Giles LC, Glonek GFV, Moore VM, et al. Lower age at menarche affects survival in older Australian women: results from the Australian Longitudinal Study of Ageing. BMC Public Health. 2010;10:341. (doi:10.1186/1471-2458-10-341).
50. Remsberg KE, Demerath EW, Schubert CM, et al. Early menarche and the development of cardiovascular disease risk factors in adolescent girls: the Fels Longitudinal Study. J Clin Endocrinol Metab. 2005;90(5): 2718-2724.
51. He C, Zhang C, Hunter DJ, et al. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol. 2010;171(3):334-344.
52. Feng Y, Hong X, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis. 2008;196(2):590-597.
53. Freedman DS, Khan LK, Serdula MK, et al. The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa Heart Study. BMC Pediatr. 2003;3:3. (doi:10.1186/1471-2431-3-3).
54. Sloboda DM, Hart R, Doherty DA, et al. Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab. 2007;92(1):46-50.
55. Thankamony A, Ong KK, Ahmed ML, et al. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. J Clin Endocrinol Metab. 2012;97(5):E786-E790.
56. Yuan R, Meng Q, Nautiyal J, et al. Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains. Proc Natl Acad Sci U S A. 2012;109(21):8224-8229.
57. Jacobsen BK, Heuch I, Kvåle G Age at natural menopause all-cause mortality: a 37-year follow-up of 19, 731 Norwegian women. Am J Epidemiol. 2003;157(10): 923-929.
58. Ossewaarde ME, Bots ML, Verbeek ALM, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16(4):556-562.
59. Mondul AM, Rodriguez C, Jacobs EJ, et al. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005;162(11):1089-1097.
60. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol. 1998;8(4):229-235.
61. Amagai Y, Ishikawa S, Gotoh T, et al. Age at menopause and mortality in Japan: the Jichi Medical School Cohort Study. J Epidemiol. 2006;16(4):161-166.
62. Cui R, Iso H, Toyoshima H, et al. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol. 2006;16(5):177-184.
63. Hong JS, Yi S-W, Kang HC, et al. Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study. Maturitas. 2007;56(4):411-419.
64. Kirkwood TB, Austad SN. Why do we age? Nature. 2000;408(6809):233-238.
65. Kenyon C. A pathway that links reproductive status to lifespan in Caenorhabditis elegans. Ann N Y Acad Sci. 2010;1204:156-162.
66. Miller RA, Harper JM, Dysko RC, et al. Longer life spans and delayed maturation in wild-derived mice. Exp Biol Med (Maywood). 2002;227(7):500-508.
67. Perls TT, Alpert L, Fretts RC. Middle-aged mothers live longer. Nature. 1997;389(6647):133.
68. Tabatabaie V, Atzmon G, Rajpathak SN, et al. Exceptional longevity is associated with decreased reproduction. Aging (Albany NY). 2011;3(12):1202-1205.
69. Gagnon A, Smith KR, Tremblay M, et al. Is there a trade-off between fertility and longevity? A comparative study of women from three large historical databases accounting for mortality selection. Am J Hum Biol. 2009; 21(4):533-540.
70. Smith KR, Gagnon A, Cawthon RM, et al. Familial aggregation of survival and late female reproduction. J Gerontol A Biol Sci Med Sci. 2009;64(7):740-744.
71. Murabito JM, Yuan R, Lunetta KL. The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J Gerontol A Biol Sci Med Sci. 2012;67(5):470-479.
72. Browner WS, Kahn AJ, Ziv E, et al. The genetics of human longevity. Am J Med. 2004;117(11):851-860.
73. Psaty BM, O'Donnell CJ, Gudnason V, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73-80.
74. Willcox BJ, Donlon TA, He Q, et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A. 2008;105(37):13987- 13992.
75. Anselmi CV, Malovini A, Roncarati R, et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009;12(2): 95-104.
76. Flachsbart F, Caliebe A, Kleindorp R, et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A. 2009; 106(8):2700-2705.
77. Li Y, Wang W-J, Cao H, et al. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum Mol Genet. 2009;18(24): 4897-4904.
78. Soerensen M, Dato S, Christensen K, et al. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell. 2010;9(6):1010-1017.
79. Pawlikowska L, Hu D, Huntsman S, et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009;8(4): 460-472.
80. Deelen J, Beekman M, Uh H-W, et al. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell. 2011;10(4):686-698.
81. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6(1):29-32.
82. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet. 2006;7(6):436-448.
83. Nebel A, Kleindorp R, Caliebe A, et al. A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev. 2011;132(6-7):324-330.
84. Sebastiani P, Solovieff N, Dewan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS ONE. 2012;7(1):e29848. (doi:10.1371/journal.pone.0029848).
85. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832-1840.
86. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47-55.
87. Reiner AP, Barber MJ, Guan Y, et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet. 2008;82(5):1193-1201.
88. Barzilai N, Atzmon G, Schechter C, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA. 2003;290(15): 2030-2040.
89. Koropatnick TA, Kimbell J, Chen R, et al. A prospective study of high-density lipoprotein cholesterol, cholesteryl ester transfer protein gene variants, and healthy aging in very old Japanese-American men. J Gerontol A Biol Sci Med Sci. 2008;63(11):1235-1240.
90. Beekman M, Nederstigt C, Suchiman HED, et al. Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci U S A. 2010;107(42):18046-18049.
91. Jeck WR, Siebold AP, Sharpless NE. Review: a meta-analysis of GWAS age-associated diseases. Aging Cell. 2012;11(5):727-731.
92. Nebel A, Flachsbart F, Till A, et al. A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech Ageing Dev. 2009; 130(10):691-699.
93. Conneely KN, Capell BC, Erdos MR, et al. Human longevity and common variations in the LMNA gene: a meta-analysis. Aging Cell. 2012;11(3):475-481.
94. Sebastiani P, Montano M, Puca A, et al. RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans. PLoS ONE. 2009;4(12):e8210. (doi:10.1371/journal.pone.0008210).
95. Barzilai N, Gabriely I, Atzmon G, et al. Genetic studies reveal the role of the endocrine and metabolic systems in aging. J Clin Endocrinol Metab. 2010;95(10):4493-4500.
96. Stolk L, Perry JRB, Chasman DI, et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012;44(3):260-268.
97. Newman AB, Boudreau RM, Naydeck BL, et al. A physiologic index of comorbidity: relationship to mortality and disability. J Gerontol A Biol Sci Med Sci. 2008;63(6): 603-609.
98. Yaffe K, Lindquist K, Vittinghoff E, et al. The effect of maintaining cognition on risk of disability and death. J Am Geriatr Soc. 2010;58(5):889-894.
99. Cauley JA, Lui L-Y, Barnes D, et al. Successful skeletal aging: a marker of low fracture risk and longevity. The Study of Osteoporotic Fractures (SOF). J Bone Miner Res. 2009;24(1):134-143.
100. Matteini AM, Fallin MD, Kammerer CM, et al. Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci. 2010;65(12):1375-1379.
101. Keinan A, Clark AG. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science. 2012;336(6082):740-743.
102. Gombar S, Jung HJ, Dong F, et al. Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics. 2012; 13(1):353. (doi:10.1186/1471-2164-13-353).
103. Harries LW, Fellows AD, Pilling LC, et al. Advancing age is associated with gene expression changes resembling mTOR inhibition: evidence from two human populations. Mech Ageing Dev. 2012;133(8):556-562.
104. Painter RC, Osmond C, Gluckman P, et al. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG. 2008;115(10):1243-1249.
105. Lumey LH, Terry MB, Delgado-Cruzata L, et al. Adult global DNA methylation in relation to pre-natal nutrition. Int J Epidemiol. 2012;41(1):116-123.
106. Tobi EW, Slagboom PE, Van Dongen J, et al. Prenatal famine and genetic variation are independently and additively associated with DNA methylation at regulatory loci within IGF2/H19. PLoS ONE. 2012;7(5):e37933. (doi:10.1371/journal.pone.0037933).
107. Van Hoek M, Langendonk JG, De Rooij SR, et al. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes. 2009;58(6):1440-1444.
108. Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann N YAcad Sci. 2007;1114:434-455.
109. Guralnik JM, Kaplan GA. Predictors of healthy aging: prospective evidence from the Alameda County Study. Am J Public Health. 1989;79(6):703-708.
110. Strawbridge WJ, Cohen RD, Shema SJ, et al. Successful aging: predictors and associated activities. Am J Epidemiol. 1996;144(2):135-141.
111. Reed DM, Foley DJ, White LR, et al. Predictors of healthy aging in men with high life expectancies. Am J Public Health. 1998;88(10):1463-1468.
112. Britton A, Shipley M, Singh-Manoux A, et al. Successful aging: the contribution of early-life and midlife risk factors. J Am Geriatr Soc. 2008;56(6):1098-1105.
113. Sun Q, Townsend MK, Okereke OI, et al. Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study. BMJ. 2009;339: b3796. (doi:10.1136/bmj.b3796).
114. Swindell WR, Ensrud KE, Cawthon PM, et al. Indicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival. BMC Geriatr. 2010;10:55. (doi:10.1186/1471- 2318-10-55).
115. Dutta A, Henley W, Lang I, et al. Predictors of extraordinary survival in the Iowa Established Populations for Epidemiologic Study of the Elderly: cohort follow-up to "extinction." J Am Geriatr Soc. 2011;59(6):963-971.
116. Gerdes LU, Jeune B, Ranberg KA, et al. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians, middle-aged men: apolipoprotein E gene is a "frailty gene, " not a "longevity gene." Genet Epidemiol. 2000;19(3): 202-210.
117. Bathum L, Christiansen L, Jeune B, et al. Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. J Am Geriatr Soc. 2006;54(4):654-658.
118. Jacobsen R, Martinussen T, Christiansen L, et al. Increased effect of the ApoE gene on survival at advanced age in healthy and long-lived Danes: two nationwide cohort studies. Aging Cell. 2010;9(6):1004-1009.
119. Cellini E, Nacmias B, Olivieri F, et al. Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev. 2005;126(6-7): 826-828.
120. Soerensen M, Dato S, Tan Q, et al. Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity [published online ahead of print January 12, 2012]. Age (Dordr). (doi:10.1007/s11357-011-9373-7).
121. Arking DE, Atzmon G, Arking A, et al. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res. 2005;96(4):412-418.
122. Atzmon G, Rincon M, Schechter CB, et al. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol. 2006;4(4):e113. (doi:10.1371/journal.pbio.0040113).
123. Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008;105(9):3438-3442.
124. Newman AB, Walter S, Lunetta KL, et al. A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci. 2010;65(5):478-487.
125. Malovini A, Illario M, Iaccarino G, et al. Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res. 2011;14(3): 283-291.
126. Willcox BJ, Willcox DC, He Q, et al. Siblings of Okinawan centenarians share lifelong mortality advantages. J Gerontol A Biol Sci Med Sci. 2006;61(4):345-354.
127. Walter S, Atzmon G, Demerath EW, et al. A genome-wide association study of ageing. Neurobiol Aging. 2011;32(11): 2109.e15-2109.e28.
128. Sebastiani P, Riva A, Montano M, et al. Whole genome sequences of a male and female supercentenarian, ages greater than 114 years. Front Genet. 2011;2:Article 90. (doi:10.3389/fgene.2011.00090).